| Title : Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models - Kim_2017_Arch.Pharm.Res_40_268 |
| Author(s) : Kim MK , Chae YN , Ahn GJ , Shin CY , Choi SH , Yang EK , Sohn YS , Son MH |
| Ref : Arch Pharm Res , 40 :268 , 2017 |
| Abstract : |
| PubMedSearch : Kim_2017_Arch.Pharm.Res_40_268 |
| PubMedID: 27885461 |
| Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65 |
| Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH |
| Ref : European Journal of Pharmacology , 771 :65 , 2016 |
| Abstract : |
| PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65 |
| PubMedID: 26621343 |
| Title : DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes - Kim_2012_Life.Sci_90_21 |
| Author(s) : Kim MK , Chae YN , Kim HD , Yang EK , Cho EJ , Choi SH , Cheong YH , Kim HS , Kim HJ , Jo YW , Son MH , Kim SH , Shin CY |
| Ref : Life Sciences , 90 :21 , 2012 |
| Abstract : |
| PubMedSearch : Kim_2012_Life.Sci_90_21 |
| PubMedID: 22056373 |
| Title : Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes - Kim_2011_Bioorg.Med.Chem.Lett_21_3809 |
| Author(s) : Kim HJ , Kwak WY , Min JP , Lee JY , Yoon TH , Kim HD , Shin CY , Kim MK , Choi SH , Kim HS , Yang EK , Cheong YH , Chae YN , Park KJ , Jang JM , Choi SJ , Son MH , Kim SH , Yoo M , Lee BJ |
| Ref : Bioorganic & Medicinal Chemistry Lett , 21 :3809 , 2011 |
| Abstract : |
| PubMedSearch : Kim_2011_Bioorg.Med.Chem.Lett_21_3809 |
| PubMedID: 21570283 |